Intervention for vascular occlusive disease of the distal lower extremity i
n elderly patients will inevitably be scrutinized as medical resources decl
ine, The authors applied surgical decision analysis to three treatment opti
ons: revascularization, amputation and expectant management. The appropriat
e outcome probabilities were derived from our experience with revasculariza
tion to the tibial and pedal vessels, and utility scores were obtained by f
ormalized patient assessment. Revascularization was predicted to improve pa
tient outcome by 1.10 quality-adjusted life-years compared with primary amp
utation and by 1.16 quality-adjusted life-years compared with expectant man
agement, To gain one additional quality-adjusted life-years, revascularizat
ion would cost $5280 more than expectant management, but $33,900 less than
primary amputation. Sensitivity analysis predicted revascularization to be
the least costly treatment per quality-adjusted life-years as long as 1-mon
th patency exceeds 11%. Revascularization for limb-threatening ischemia of
the distal lower extremity is justified and can be performed at a reasonabl
e cost. (C) 1998 The International Society for Cardiovascular Surgery. Publ
ished by Elsevier Science Ltd. All rights reserved.